BioSpace News Archive

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced FDA clearance for use of Fiasp® with the Omnipod® Insulin Management System and the Omnipod DASH™ Insulin Management System for adults.

MediPharm Labs Corp is pleased to announce that its co-founders, Pat McCutcheon and Keith Strachan, were named as finalists in the EY Ontario Entrepreneur of the Year Award in the Health & Life Sciences category.

Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2019, reported net income was $4.7 million, or $.34 per diluted share, as compared to $4.4 million, or $.32 per diluted share, during the third quarter of 2018.

Allergan plc announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the fourth quarter of 2019.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today celebrates its third annual Day for Doing Good, a company-wide global day of service.

Choom™ (CSE: CHOO; OTCQB: CHOOF) is very pleased to announce the appointment of Corey Gillon as the company’s new Chief Executive Officer effective Monday, December 1, 2019, and subject to provincial regulatory approvals.

Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, today announced that it will release corporate and financial results for the third quarter that ended September 30, 2019 before the open of the U.S. financial markets on Friday, November 8, 2019

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced the pricing of its initial public offering of 6,800,000 shares of common stock at a price to the public of $11.00 per share.

The Prix Galien USA Committee last night honored excellence in the biopharmaceutical and medical industry for research, development and innovation at its 13th annual Prix Galien Awards Gala, held at the American Museum of Natural History in New York City.

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report financial results for the fourth quarter and Fiscal Year 2019 following the close of regular trading on Tuesday, November 12, 2019.